PubRank

Nancy Y Lee

Author PubWeight™ 74.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 2012 2.71
2 The abscopal effect associated with a systemic anti-melanoma immune response. Int J Radiat Oncol Biol Phys 2012 2.29
3 Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2007 2.23
4 Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2005 2.04
5 Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2011 1.80
6 Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2010 1.77
7 Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer. J Nucl Med 2008 1.65
8 Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. Int J Radiat Oncol Biol Phys 2008 1.64
9 Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2009 1.58
10 Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how, and how much? Int J Radiat Oncol Biol Phys 2011 1.56
11 Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2008 1.51
12 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma. J Nucl Med 2012 1.32
13 Decision making in the management of recurrent head and neck cancer. Head Neck 2013 1.31
14 Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience. Cancer 2008 1.31
15 Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience. Int J Radiat Oncol Biol Phys 2006 1.29
16 Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys 2008 1.27
17 Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET. Int J Radiat Oncol Biol Phys 2011 1.26
18 Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging. Phys Med Biol 2009 1.22
19 Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2008 1.20
20 Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review. Radiother Oncol 2011 1.18
21 Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes. Int J Radiat Oncol Biol Phys 2011 1.17
22 Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma. Cancer Immunol Res 2013 1.16
23 Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. Int J Radiat Oncol Biol Phys 2009 1.16
24 Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. Int J Radiat Oncol Biol Phys 2007 1.16
25 Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys 2008 1.15
26 Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys 2007 1.15
27 Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys 2011 1.14
28 Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer. J Nucl Med 2009 1.12
29 Dorsal vagal complex of the brainstem: Conformal avoidance to reduce nausea. In regard to Monroe et al. Pract Radiat Oncol 2015 1.06
30 A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy. Cancer 2014 1.02
31 A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer. Cancer 2012 1.02
32 Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients. Cancer Prev Res (Phila) 2009 0.97
33 Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer. Int J Cancer 2013 0.96
34 Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer. Int J Radiat Oncol Biol Phys 2005 0.96
35 Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience. Thyroid 2013 0.92
36 Radiotherapy after surgical resection for head and neck mucosal melanoma. Am J Clin Oncol 2010 0.92
37 Elective versus Therapeutic Neck Dissection in Oral Cancer. N Engl J Med 2015 0.91
38 Using an onboard kilovoltage imager to measure setup deviation in intensity-modulated radiation therapy for head-and-neck patients. J Appl Clin Med Phys 2007 0.91
39 Merkel cell carcinoma. J Natl Compr Canc Netw 2009 0.90
40 Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy. Cancer 2012 0.90
41 Comparison of intensity-modulated radiotherapy using helical tomotherapy and segmental multileaf collimator-based techniques for nasopharyngeal carcinoma: dosimetric analysis incorporating quality assurance guidelines from RTOG 0225. Technol Cancer Res Treat 2010 0.89
42 Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer 2009 0.89
43 Evaluation of hereditary risk in a mammography population. Clin Breast Cancer 2005 0.88
44 Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 2010 0.88
45 Microcystic adnexal carcinoma of the face treated with radiation therapy: a case report and review of the literature. Head Neck 2011 0.87
46 Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. Int J Radiat Oncol Biol Phys 2007 0.87
47 Dosimetric distribution to the tooth-bearing regions of the mandible following intensity-modulated radiation therapy for base of tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 2012 0.86
48 A risk-adapted approach to the use of radioactive iodine and external beam radiation in the treatment of well-differentiated thyroid cancer. Cancer Control 2011 0.85
49 Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapy. Oncologist 2012 0.84
50 Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation? Int J Radiat Oncol Biol Phys 2007 0.84
51 Concurrent chemotherapy and radiotherapy for head and neck cancer. Expert Rev Anticancer Ther 2009 0.84
52 External beam radiotherapy with or without concurrent chemotherapy in advanced or recurrent non-anaplastic non-medullary thyroid cancer. J Surg Oncol 2014 0.84
53 Pathologically determined tumor volume vs pathologic T stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 2013 0.83
54 Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma. Radiat Oncol 2013 0.82
55 Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer. Am J Clin Oncol 2008 0.82
56 Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 2007 0.82
57 A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2013 0.82
58 Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer. Am J Clin Oncol 2008 0.81
59 Fistula formation after postoperative radiation treatment for paranasal sinus cancer. Am J Clin Oncol 2008 0.81
60 Radiation therapy for cutaneous melanoma. Dermatol Clin 2012 0.81
61 Dermatofibrosarcoma protuberans. J Natl Compr Canc Netw 2007 0.79
62 Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes. Am J Clin Oncol 2015 0.78
63 Radiation therapy in the treatment of minor salivary gland tumors. Am J Clin Oncol 2014 0.77
64 The distance discordance metric-a novel approach to quantifying spatial uncertainties in intra- and inter-patient deformable image registration. Phys Med Biol 2014 0.77
65 High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer. Brachytherapy 2013 0.77
66 Merkel cell carcinoma. J Natl Compr Canc Netw 2006 0.76
67 Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer. EJNMMI Res 2013 0.76
68 The role of radiation therapy in the treatment of medullary thyroid cancer. J Natl Compr Canc Netw 2010 0.76
69 An unusual cause of isolated vomiting. Neurology 2012 0.75
70 Intensity-modulated radiation therapy for head and neck cancer. Expert Rev Anticancer Ther 2005 0.75
71 Racial disparities in the use of voice preservation therapy for locally advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2012 0.75
72 Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics. Phys Med Biol 2017 0.75